Drug Makers' Settlement Pact Not Illegal
Source: The New York Law Journal. Reprinted with permission.
The U.S. Court of Appeals for the Federal Circuit ruled that an agreement settling a patent dispute did not violate antitrust law because it did not restrain competition beyond the scope of the patent. The Federal Trade Commission (FTC) challenged an agreement to divide markets along the U.S.- Canada border that was extended beyond the term of a legitimate collaboration between golf store chains.
Drug Makers’ Settlement Pact Not Illegal.pdf (pdf | 213.10 KB )